Skip to main content
Bioton S.A. logo

Bioton S.A. — Investor Relations & Filings

Ticker · BIO ISIN · PLBIOTN00029 LEI · 259400I5R1L3OPCGII81 WAR Manufacturing
Filings indexed 697 across all filing types
Latest filing 2017-02-08 Board/Management Inform…
Country PL Poland
Listing WAR BIO

About Bioton S.A.

https://bioton.com/en/

Bioton S.A. is a biotechnology company focused on providing comprehensive solutions for diabetes care. The company's core activity is the development and production of recombinant human insulin, positioning it as a significant commercial manufacturer globally. Its operations cover the full biotechnological process, from DNA research and development to the manufacturing and marketing of finished medicinal products. The product portfolio is centered on various forms of insulin and is complemented by modern automatic injection systems designed to facilitate effective diabetes treatment for patients.

Recent filings

Filing Released Lang Actions
Rezygnacja osoby nadzorującej BIOTON S.A. - Content (PL)
Board/Management Information Classification · 98% confidence The document text is very short (439 characters) and announces a specific change in company leadership: the resignation of Mr. Marcin Dukaczewski from the Supervisory Board (Wiceprzewodniczący Rady Nadzorczej). This directly corresponds to the definition of Board/Management Information, which covers announcements of changes in the company's board of directors or senior management.
2017-02-08 Polish
Terminarz publikacji raportów okresowych BIOTON S.A. w roku 2017 - Content (PL)
Report Publication Announcement Classification · 98% confidence The document explicitly outlines the schedule for the company's periodic reports (quarterly, semi-annual, and annual reports) for the year 2017, referencing specific Polish financial regulations ('Rozporządzenie Ministra Finansów'). This document is not the report itself (like an IR or 10-K), but rather an announcement detailing *when* those reports will be published. This fits the definition of a Report Publication Announcement (RPA), which signals the timing of future report releases.
2017-01-28 Polish
Korekta Raportu Bieżącego Bioton S.A. nr 55/2016 z dnia 02 grudnia 2016 r. - Content (PL)
Major Shareholding Notification Classification · 99% confidence The document is a correction ('koryguje treść Raportu Bieżącego') to a previous current report (Raport Bieżący nr 55/2016) concerning changes in shareholding percentages and voting rights held by specific individuals and entities (Mr. Zhu Jiman, Millionview Limited, etc.). This type of filing, which reports changes in significant share ownership thresholds (crossing 5% or 10%), directly corresponds to the definition of Major Shareholding Notification (MRQ) under Polish regulations, which is equivalent to the concept covered by the MRQ code in the provided schema (Notification of changes in significant share ownership levels). Although it is a correction to a 'Raport Bieżący' (Current Report), the core subject matter is the change in major shareholding, making MRQ the most specific fit over the general RNS category. The document is substantial (7350 chars) and contains the full details, not just an announcement of a report.
2016-12-21 Polish
RB_2016_57_zalacznik.pdf
Director's Dealing Classification · 98% confidence The document is titled "Powiadomienie o transakcjach, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of transactions referred to in Article 19(1) of the MAR Regulation). It details a transaction (Nabycie - Acquisition) involving shares of BIOTON S.A. by an entity closely associated with a member of management (Panem Jubo Liu, Prezesem Zarządu). Article 19 of MAR (Market Abuse Regulation) specifically deals with transactions conducted by persons discharging managerial responsibilities (PDMRs) and persons closely associated with them. This type of filing reports insider trading or transactions by management/directors. Among the provided codes, 'DIRS' (Director's Dealing) is the most appropriate category for reporting personal share transactions by company directors and executives (insider trades), even though the notification is made by a closely associated person/entity.
2016-12-05 Polish
Powiadomienie w trybie art. 19 ust. 1 rozporządzenia MAR. - Content (PL)
Director's Dealing Classification · 98% confidence The document text is a formal notification in Polish regarding a transaction involving shares of BIOTON S.A. It explicitly mentions receiving a notification about a transaction as per Article 19(1) of the MAR regulation (Market Abuse Regulation). The details provided include the name of the related party (UniApek S.A.), the reason (being closely associated with the CEO, Mr. Jubo Liu), the instrument (Bioton S.A. shares), the transaction type ('Nabycie' - Acquisition), price, volume, and date. This structure perfectly matches the definition of insider trading reports or director's dealings, which in the provided schema is 'Director's Dealing' (DIRS). The document is short and contains the full details, so it is not an RPA.
2016-12-05 Polish
Zawiadomienie o zwiększeniu udziału w ogólnej liczbie głosów w Bioton S.A. - Content (PL)
Major Shareholding Notification Classification · 98% confidence The document is a formal notification from BIOTON S.A. detailing the acquisition of a significant number of company shares (8,586,419 shares, representing approximately 9.99% of the share capital) by two parties, Dezhao Kong and Perfect Trend Ventures Limited. The notification explicitly references Polish securities law articles (art. 69 ust. 1 pkt. 1, art. 69 ust. 2 pkt. 1 lit. a, etc.) concerning changes in significant share ownership thresholds. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing defined thresholds.
2016-12-05 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.